SCHEMBL132084

SCHEMBL132084

C=CC1(O)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130275 0.93
SCHEMBL4418854 0.90 ALDH1A1 (0.33)
SCHEMBL4416587 0.90 ALDH1A1 (0.33)
SCHEMBL4417953 0.90 ALDH1A1 (0.33)
SCHEMBL4416531 0.90 ALDH1A1 (0.33)
SCHEMBL4419210 0.90 ALDH1A1 (0.33)
SCHEMBL493926 0.90
SCHEMBL4416288 0.90 ALDH1A1 (0.33)
SCHEMBL21869877 0.90 ALDH1A1 (0.33)
SCHEMBL4416520 0.90 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116120295-A N-substituted imidazole formate derivative and application thereof 成都麻沸散医药科技有限公司 2023-05-16 CN disclosed
US-11434205-B2 Substituted imidazole carboxylate derivatives and the use thereof CHENGDU MFS PHARMA. CO., LTD. (CN) 2022-09-06 US disclosed
WO-2021191872-A1 HETEROARYL-SUBSTITUTED MACROCYCLIC FLU ENDONUCLEASE INHIBITORS Janssen Biopharma, Inc. (US) 2021-09-30 WO disclosed
EP-3747869-A1 SUBSTITUTED IMIDAZOLE FORMATE DERIVATIVE AND USE THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2020-12-09 EP disclosed
EP-3747869-A1 SUBSTITUTED IMIDAZOLE FORMATE DERIVATIVE AND USE THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2020-12-09 EP disclosed
US-20200369621-A1 SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2020-11-26 US disclosed
US-20200369621-A1 SUBSTITUTED IMIDAZOLECARBOXYLATE DERIVATIVES AND THE USE THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2020-11-26 US disclosed
WO-2019149228-A1 SUBSTITUTED IMIDAZOLE FORMATE DERIVATIVE AND USE THEREOF 成都安诺晨创医药科技有限公司 2019-08-08 WO disclosed
CN-109776512-A N-substituted imidazole formate derivative and application thereof 成都安诺晨创医药科技有限公司 2019-05-21 CN disclosed
EP-2686369-B1 MULTIFUNCTIONAL SULFUR-CONTAINING POLYMERS, COMPOSITIONS THEREOF AND METHODS OF USE PRC DESOTO INT INC (US) 2018-12-19 EP disclosed
EP-1278742-A1 CHROMENYLMETHYLPYRIMIDINEDIAMINES AS ANTIBACTERIAL AGENTS Basilea Pharmaceutica AG (CH) 2003-01-29 EP disclosed
WO-2001083476-A1 CHROMENYLMETHYL PYRIMIDINEDIAMINES AS ANTIBACTERIAL AGENTS BASILEA PHARMACEUTICA AG (CH) 2001-11-08 WO disclosed
US-5607960-A Indole derivatives as 5-HT1-like agonists for use in migraine PFIZER INC. (US) 1997-03-04 US disclosed
EP-0695301-B1 INDOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS FOR USE IN MIGRAINE PFIZER LTD (GB) 1996-10-30 EP disclosed
CN-1121348-A Indole derivatives as 5-H1-like agonists for use in migraine PFIZER RES & DEV (IE) 1996-04-24 CN disclosed
EP-0695301-A1 INDOLE DERIVATIVES AS 5-H1-LIKE AGONISTS FOR USE IN MIGRAINE PFIZER LTD (GB) 1996-02-07 EP disclosed
WO-1994024127-A1 INDOLE DERIVATIVES AS 5-H1-LIKE AGONISTS FOR USE IN MIGRAINE PFIZER LIMITED (GB) 1994-10-27 WO disclosed
US-4206140-A INSECTICIDES, ANTHELMINTICS ROUSSEL UCLAF (FR) 1980-06-03 US disclosed
US-4101574-A Cyclopropanecarboxylic acid chlorides ROUSSEL UCLAF (FR) 1978-07-18 US disclosed
US-3997586-A Cyclopropanecarboxylic acids and esters ROUSSEL-UCLAF (FR) 1976-12-14 US disclosed